There are 2949 resources available
Flattening the curve: Consequences for the management of prostate cancer in the ongoing COVID-19 pandemic
Presenter: Boris Hadaschik
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast
Live Q&A - 18 September 2020 - 17:00-18:00
Presenter: Boris Hadaschik
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast
An overview of NSCLC
Presenter: Marina Garassino
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Uncommon EGFR mutations in NSCLC
Presenter: Zofia Piotrowska
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:00-17:30
Presenter: Eva Ciruelos
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:30-18:00
Presenter: Arndt Vogel
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Welcome and Introduction
Presenter: Markus Möhler
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Current status of I-O for the treatment of metastatic colorectal cancer
Presenter: Sara Lonardi
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
I-O for upper GI cancers: Where are we today?
Presenter: Elizabeth Smyth
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Case study workshop: Expert insights into I-O therapy for GI cancers
Presenter: Elizabeth Smyth
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast